Acquiring Company
Astellas
Acquired Company
Iveric Bio
ParsippanyBiotechnologyHealth CareMedicalPharmaceuticalPharmaceutical ManufacturingBiotechnologyHealth CareTherapeuticsDescription
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it has successfully completed the acquisition of IVERIC bio, Inc. (NASDAQ: ISEE, CEO: Glenn P. Sblendorio, "Iveric Bio") with respect to the announcement on April 30, 2023, through its indirect wholly-owned subsidiary Berry Merger Sub, Inc. (the "Acquisition"). The Acquisition was completed on July 11, 2023, US Eastern Time, as follows, and Iveric Bio has become Astellas' wholly-owned subsidiary.
Quick answer
Astellas is acquiring Iveric Bio, announced July 11, 2023.
- How much did Astellas pay for Iveric Bio?
- The deal value was not disclosed.
- What does Astellas do?
- Astellas Pharma US, Inc. is an affiliate of Tokyo-based Astellas Pharma Inc., a top 20 global pharmaceutical research company.
- Where are Astellas and Iveric Bio based?
- Iveric Bio is based in Parsippany, New Jersey, United States.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Lilly Completes Acquisition Of Dice Therapeutics (August 9, 2023)
- Lilly To Acquire Versanis To Improve Patient Outcomes In Cardiometabolic Diseases (July 14, 2023)
- Lilly To Acquire Dice Therapeutics To Advance Innovation In Immunology (June 20, 2023)
- Theken Companies Acquires Visionair Solutions (August 22, 2023)
- Lilly Completes Acquisition Of Sigilon Therapeutics (August 14, 2023)
- Regeneron To Acquire Decibel Therapeutics, Strengthening Gene Therapy And Hearing Loss Programs (August 9, 2023)
Who to call at Astellas, and when
When Astellas changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Astellas raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Astellas, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Astellas. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Astellas makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Iveric Bio?
Iveric Bio was acquired by Astellas. The deal was reported on July 11, 2023. Astellas Pharma US, Inc. is an affiliate of Tokyo-based Astellas Pharma Inc., a top 20 global pharmaceutical research company. Astellas is privately held and operates in Biotechnology.
When did Astellas acquire Iveric Bio?
Astellas's acquisition of Iveric Bio was reported on July 11, 2023. Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it has successfully completed the acquisition of IVERIC bio, Inc. (NASDAQ: ISEE, CEO: Glenn P. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Iveric Bio do?
Iveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs. It is privately held, operating in Biotechnology, and is based in Parsippany.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.